AntibodyChecks - 5-10% Fee On Lifetime Sales for COVID-19 Testing Kits

Press Release: June 23, 2020

  • Share This Article
  • Facebook
  • Twitter
  • Pintrest
  • LinkedIn
  • Mail
AntibodyChecks - 5-10% Fee On Lifetime Sales for COVID-19 Testing Kits

AntibodyChecks focus on providing businesses and corporations access to accurate, accredited and affordable COVID-19 antibody testing devices that can be performed onsite with results delivered in 15 minutes.



AntibodyChecks are offering a 5-10% referral fee on lifetime sales to any one that refers AntibodyChecks into another business, volume dependent. The tests start from £24 per test in packets of 30 (£720 for one unit), which can quickly scale to 1,000s of pounds with volume.

 

The tests are much more affordable from £24 per test (subject to volume) versus £40-£50 laboratory testing which can also take 2-3 days for results. These tests help businesses as an alternative, with quick and affordable testing data to ensure they are making informed decisions when it comes to the workplace and workforce.


Why OnSite Antibody Rapid Test Kits?

  • Reliable: 96.9% in sensitivity and 99.4% in specificity
  • Quick: Results in 15 minutes from a blood sample
  • Onsite: Test performed onsite in minutes
  • Affordable: COVID-19 Antibody tests from £24 per test
  • Comfort: Employees will be more comfortable in returning to the office
  • Trackable: Invaluable data to drive business and COVID-19 decisions
  • Transmission: Develop the right in-office measures through data
  • Accredited: The tests are CE Certified, ISO Registered and MRHA has allowed the product to be placed on the UK market for professional use

 

COVID-19 OnSite Antibody Rapid Tests are now available from AntibodyChecks.com from £24 per test with free delivery to one location in the UK.

 

For further information on this story, the OnSite Rapid Test or the survey, contact:

Mayur Vohra, Founder of AntibodyChecks

Enquiries: team@antibodychecks.com

Contact: +447817 616373

www.antibodychecks.com

 


  • Share This Article
  • Facebook
  • Twitter
  • Pintrest
  • LinkedIn
  • Mail